This contribution initially describes some traditional tools that are commonly used to measure drug tolerability, including measures that take into considerations both clinicians' and patients' views. Subsequently, it highlights a few studies that compared the patient and clinician's perspective in the evaluation of drug tolerability, trying to understand whether health care providers and patients perceive antipsychotic tolerability in different ways, and whether these different ways may have implications in terms of treatment adherence and outcome. Finally, some clinical and research implications are suggested and discussed.
|Titolo:||Tolerability of antipsychotic drugs: does patient perspective deserve consideration?|
NOSE', Michela (Corresponding)
|Data di pubblicazione:||2008|
|Appare nelle tipologie:||01.01 Articolo in Rivista|